Cumberland Pharmaceuticals Inc.
CPIX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $18 | $18 | $20 | $27 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $12 | $10 | $13 | $7 |
| Inventory | $4 | $5 | $10 | $8 |
| Other Curr. Assets | $3 | $3 | $3 | $3 |
| Total Curr. Assets | $36 | $36 | $46 | $46 |
| Property Plant & Equip (Net) | $6 | $7 | $6 | $1 |
| Goodwill | $1 | $1 | $1 | $1 |
| Intangibles | $18 | $23 | $31 | $24 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $14 | $15 | $10 | $12 |
| Total NC Assets | $39 | $46 | $47 | $39 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $76 | $82 | $93 | $84 |
| Liabilities | – | – | – | – |
| Payables | $14 | $14 | $11 | $10 |
| Short-Term Debt | $5 | $0 | $0 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $12 | $14 | $18 | $9 |
| Total Curr. Liab. | $32 | $28 | $29 | $19 |
| LT Debt | $15 | $18 | $21 | $15 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $6 | $6 | $8 | $7 |
| Total NC Liab. | $21 | $25 | $28 | $23 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $6 | $5 | $1 |
| Total Liabilities | $53 | $53 | $57 | $42 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $47 | $47 | $47 | $48 |
| Retained Earnings | -$24 | -$17 | -$11 | -$6 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $23 | $30 | $36 | $43 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$0 | -$0 | -$0 | -$0 |
| Total Liab. & Tot. Equity | $76 | $82 | $93 | $84 |
| Net Debt | $3 | $0 | $1 | -$11 |